Collagen Solutions shares up 75% amid sale talks

Shares of Glasgow-based Collagen Solutions soared about 75% on Thursday after it announced it is in discussions “with a number of parties regarding a potential sale of the company.”

Collagen Solutions specializes in producing custom formulations of medical-grade collagen biomaterials and tissues for use in medical devices.

In a stock exchange statement, Collagen Solutions said: “The company announces that following the receipt of interest in the company it has decided to conduct a formal review of the various strategic options available to the company to maximise value for shareholders.

“These options include, but are not limited to, the potential sale of the company or the sale of one or more of the company’s assets.

“To facilitate discussions with interested parties the company announces the commencement of a ‘formal sale process’ as set out by The Takeover Code …”

Collagen Solutions has appointed England & Company, LLC and Goodbody Stockbrokers UC as joint financial advisers.

“Parties with a possible interest in submitting an indication of interest should contact England & Company or Goodbody …” said Collagen Solutions.

“The company confirms that, at the time of this announcement, it is in discussions with a number of parties regarding a potential sale of the company …”

About the Author

Mark McSherry
Dalriada Media LLC sites are edited by veteran news journalist Mark McSherry, a former staff editor and reporter with Reuters, Bloomberg and major newspapers including the South China Morning Post, London's Sunday Times and The Scotsman. McSherry's journalism has also appeared in The Washington Post, The Guardian, The Independent, The New York Times, London's Evening Standard and Forbes. McSherry is also a professor of journalism and communication arts in universities and colleges in New York City. Scottish-born McSherry has an MBA from the University of Edinburgh and a Certificate in Global Affairs from New York University.